BRCA2 and breast carcinoma: In a landmark study, anti-DNA antibodies were found to be lethal to BRCA2-deficient human cancer cells [11], suggesting that the presence of lupus autoantibodies may contribute to the decreased risk of breast cancer observed in SLE patients.